AAT-AD/PD Focus Meeting

Centro Congressi Lingotto
Torino, Italy
2018, March 15—18

The Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

A central theme will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers discussed in the sessions and corridors at AD/PDTM 2017, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative drugs and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.

http://www.aat-adpd.kenes.com

Sign up to meet GCT representatives at this meeting




I have read, understood and agreed to Terms of Service and Privacy Policy.
I agree to be contacted by a GCT representative to clarify any details regarding the potential meeting and collaboration prospectives.



About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2018 Global Clinical Trials, LLC

All rights reserved.